References
- Alteri C.J., Hagan E.C., Sivick K.E., Smith S.N., Mobley H.L.: Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5, e1000586 (2009)
- Asadi Karam M.R., Habibi M., Bouzari S.: Urinary tract infection: pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol. Immunol. 108, 56–67 (2019)
- Awasthi T.R., Pant N.D., Dahal P.R.: Prevalence of multidrug resistant bacteria in causing community acquired urinary tract infection among the patients attending outpatient Department of Seti Zonal Hospital, Dhangadi, Nepal. Nepal. J. Biotechnol. 3, 55–59 (2015)
- Baldy-Chudzik K., Bok E., Mazurek J.: Znane i nowe warianty patogennych Escherichia coli jako konsekwencja plastycznego genomu. Post. Hig. Med. Dosw. 69, 345–361 (2015)
- Benz R., Maier E., Bauer S., Ludwig A.: The deletion of several amino acid stretches of Escherichia coli alpha-Hemolysin (HlyA) suggests that the channel-forming domain contains beta-strands. PLoS One, 9, e112248 (2014)
- Bien J., Sokolova O., Bozko P.: Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol. 2012, 681473 (2012)
- Brumbaugh A.R., Mobley H.L.: Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert. Rev. Vaccines. 11, 663–676 (2012)
- Brumbaugh A.R., Smith S.N., Mobley H.L.: Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect. Immun. 81, 3309–3316 (2013)
- Carlos C., Pires M.M., Stoppe N.C., Hachich E.M., Sato M.I., Gomes T.A., Amaral L.A., Ottoboni L.M.: Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination. BMC Microbiol. 10, 161 (2010)
- Chmielewska S.J., Fiedoruk K., Daniluk T., Ściepuk M., Kaczmarzyk D., Leszczyńska K.: Znaczenie uropatogennych szczepów Escherichia coli (UPEC) w etiopatogenezie zakażeń układu moczowego. Post. Mikrobiol. 55, 45–56 (2016)
- Clermont O., Bonacorsi S., Bingen E.: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66, 4555–4558 (2000)
- Crnigoj M., Podlesek Z., Budič M., Zgur-Bertok D.: The Escherichia coli uropathogenic-specific-protein associated immunity protein 3 (Imu3) has nucleic acid-binding activity. BMC Microbiol. 14, 16 (2014)
- Croxen M.A., Finlay B.B.: Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8, 26–38 (2010)
- Dautin N.: Serine Protease Autotransporters of Enterobacteriaceae (SPATEs): biogenesis and function. Toxins (Basel), 2, 1179–1206 (2010)
- Dikshit N., Bist P., Fenlon S.N., Pulloor N.K., Chua C.E., Scidmore M.A., Carlyon J.A., Tang B.L., Chen S.L., Sukumaran B.: Intracellular uropathogenic E. coli exploits host Rab35 for iron acquisition and survival within urinary bladder cells. PLOS Pathog. 6, e1005083 (2015)
- Evans M.L., Chapman M.R.: Curli biogenesis: order out of disorder. Biochim. Biophys. Acta, 1843, 1551–1558 (2014)
- Fabbri A., Travaglione S., Fiorentini C.: Escherichia coli cytotoxic necrotizing factor 1 (CNF1): toxin biology, in vivo applications and therapeutic potential. Toxins (Basel), 2, 283–296 (2010)
- Feldmann F., Sorsa L.J., Hildinger K., Schubert S.: The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro. Infect. Immun. 75, 3183–3187 (2007)
- Floyd K.A., Moore J.L., Eberly A.R., Good J.A., Shaffer C.L., Zaver H., Almqvist F., Skaar E.P., Caprioli R.M., Hadjifrangiskou M.: Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLOS Pathog. 11, e1004697 (2015)
- Garcia E.C., Brumbaugh A.R., Mobley H.L.: Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79, 1225–1235 (2011)
- Garcia T.A., Ventura C.L., Smith M.A., Merrell D.S., O’Brien A.D.: Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun. 81, 99–109 (2013)
- Grasso F., Frisan T.: Bacterial genotoxins: merging the DNA damage response into infection biology. Biomolecules, 5, 1762–1782 (2015)
- Guo Y., Zhang Z., Wei H., Wang J., Lv J., Zhang K., Keller E.T., Yao Z., Wang Q.: Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42-PAK1 axis. J. Pathol. 243, 208–219 (2017)
- Hancock V., Ferrières L., Klemm P.: The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine. Microbiology, 154, 167–175 (2008)
- Heras B., Totsika M., Peters K.M., Paxman J.J., Gee C.L., Jarrott R.J., Perugini M.A., Whitten A.E., Schembri M.A.: The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping. Proc. Natl. Acad. Sci. USA, 111, 457–462 (2014)
- Hooton T.M., Bradley S.F., Cardenas D.D., Colgan R., Geerlings S.E., Rice J.C., Saint S., Schaeffer A.J., Tambayh P.A., Tenke P., Nicolle L.E.: Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50, 625–663 (2010)
- Hryniewicz W., Holecki M.: Rekomendacje diagnostyki, terapii i profilaktyki zakażeń układu moczowego u dorosłych, 2015, http://www.antybiotyki.edu.pl/pdf/uklmoczowyinternet.pdf (05.07.2019)
- Hufnagel D.A., Depas W.H., Chapman M.R.: The biology of the Escherichia coli extracellular matrix. Microbiol. Spectr. 3, doi: 10.1128/microbiolspec.MB-0014-2014 (2015)
- Jamet A., Nassif X.: New players in the toxin field: polymorphic toxin systems in bacteria. MBio. 6, e00285-15 (2015)
- Kanamaru S., Kurazono H., Nakano M., Terai A., Ogawa O., Yamamoto S.: Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenicspecific protein: comparison with phylogenetic groups. Int. J. Urol. 13, 754–760 (2006)
- Knudsen S.K., Stensballe A., Franzmann M., Westergaard U.B., Otzen D.E.: Effect of glycosylation on the extracellular domain of the Ag43 bacterial autotransporter: enhanced stability and reduced cellular aggregation. Biochem. J. 412, 563–577 (2008)
- Kobierecka P., Wyszyńska A., Jagusztyn-Krynicka E.K.: Charakterystyka genotoksyn CDT (cytolethal distending toxin). Post. Mikrobiol. 52, 315–324 (2013)
- Lo Y., Zhang L., Foxman B., Zöllner S.: Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence. Infect. Genet. Evol. 34, 244–250 (2015)
- Luo Y., Ma Y., Zhao Q., Wang L., Guo L., Ye L., Zhang Y., Yang J.: Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J. Clin. Microbiol. 50, 4002–4007 (2012)
- Lüthje P., Brauner A.: Virulence factors of uropathogenic E. coli and their interaction with the host. Adv. Microb. Physiol. 65, 337–372 (2014)
- Mann R., Mediati D.G., Duggin I.G., Harry E.J., Bottomley A.L.: Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front. Cell. Infect. Microbiol. 7, 241 (2017)
- Matusiak D.M.: Zakażenia układu moczowego z udziałem Proteus mirabilis – rola biofilmu i inkrustacji cewnika urologicznego. Post. Mikrobiol. 53, 173–180 (2014)
- McLellan L.K., Hunstad D.A.: Urinary tract infection: pathogenesis and outlook. Trends. Mol. Med. 22, 946–957 (2016)
- Miraglia A.G., Travaglione S., Meschini S., Falzano L., Matarrese P., Quaranta M.G., Viora M., Fiorentini C., Fabbri A.: Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/ IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2. Mol. Biol. Cell. 18, 2735–2744 (2007)
- Nipic D., Podlesek Z., Budič M., Črnigoj M., Žgur-Bertok D.: Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J. Infect. Dis. 208, 1545–1552 (2013)
- Ostrowska K., Strzelczyk A., Różalski A., Stączek P.: Biofilm bakteryjny jako przyczyna zakażeń układu moczowego – mikroorganizmy patogenne, metody prewencji i eradykacji. Postepy Hig. Med. Dosw. 67, 1027–1033 (2013)
- Paxman J.J., Heras B.: Unique structural features of a bacterial autotransporter adhesin suggest mechanisms for interaction with host macromolecules. Nat. Commun. 10, 967 (2019)
- Pérez-Moreno M.O., Pérez-Moreno M., Carulla M., Rubio C., Jardí A.M., Zaragoza J.: Mechanisms of reduced susceptibility to amoxicillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain). Clin. Microbiol. Infect. 10, 234–241 (2004)
- Piteau M., Papatheodorou P., Schwan C., Schlosser A., Aktories K., Schmidt G.: Lu/BCAM adhesion glycoprotein is a receptor for Escherichia coli cytotoxic necrotizing factor 1 (CNF1). PLOS Pathog. 10, e1003884 (2014)
- Reidl S., Lehmann A., Schiller R., Salam Khan A., Dobrindt U.: Impact of O-glycosylation on the molecular and cellular adhesion properties of the Escherichia coli autotransporter protein Ag43. Int. J. Med. Microbiol. 299, 389–401 (2009)
- Restieri C., Garriss G., Locas M.C., Dozois C.M.: Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl. Environ. Microbiol. 73, 1553–1562 (2007)
- Ristow L.C., Welch R.A.: Hemolysin of uropathogenic Escherichia coli: a cloak or a dagger. Biochim. Biophys. Acta, 1858, 538–545 (2016)
- Robinson A.E., Heffernan J.R., Henderson J.P.: The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence. Future Microbiol. 13, 745–756 (2018)
- Ruiz-Perez F., Nataro J.P.: Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence. Cell. Mol. Life. Sci. 71, 745–770 (2014)
- Sánchez-Magraner L., Viguera A.R., García-Pacios M., Garcillán M.P., Arrondo J.L., de la Cruz F., Goñi F.M., Ostolaza H.: The calcium-binding C-terminal domain of Escherichia coli alpha-hemolysin is a major determinant in the surface-active properties of the protein. J. Biol. Chem. 282, 11827–11835 (2007)
- Sarowska J., Futoma-Koloch B., Jama-Kmiecik A., Frej-Madrzak M., Ksiazczyk M., Bugla-Ploskonska G., Choroszy-Krol I.: Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut. Pathog. 11, 10 (2019)
- Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., Marchese A.: The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents, 34, 407–413 (2009)
- Sharma G., Sharma S., Sharma P., Chandola D., Dang S., Gupta S., Gabrani R.: Escherichia coli biofilm: development and therapeutic strategies. J. Appl. Microbiol. 121, 309–319 (2016)
- Sobieszczańska M.B.: Hemolizyny Escherichia coli. Post. Mikrobiol. 46, 343–353 (2007)
- Subashchandrabose S., Mobley H.L.: Virulence and fitness determinants of uropathogenic Escherichia coli. Microbiol. Spectr. 3, doi: 10.1128/microbiolspec.UTI-0015–2012 (2015)
- Terlizzi M.E., Gribaudo G., Maffei M.E.: Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front. Microbiol. 8, 1566 (2017)
- Ulett G.C., Totsika M., Schaale K., Carey A.J., Sweet M.J., Schembri M.A.: Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr. Opin. Microbiol. 16, 100–107 (2013)
- Ulett G.C., Valle J., Beloin C., Sherlock O., Ghigo J.M., Schembri M.A.: Functional analysis of Antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 75, 3233–3244 (2007)
- Vollmerhausen T.L., Katouli M.: Molecular characterization of Escherichia coli isolated from hospitalized children and adults with urinary tract infection. Eur. J. Clin. Microbiol. Infect. Dis. 33, 975–982 (2014)
- Wagenlehner F.M.E., Naber K.G.: Treatment of bacterial urinary tract infections: presence and future. Eur. Urol. 49, 235–244 (2006)
- Wallecha A., Oreh H., van der Woude M.W., de Haseth P.L.: Control of gene expression at a bacterial leader RNA, the agn43 gene encoding outer membrane protein Ag43 of Escherichia coli. J. Bacteriol. 196, 2728–2735 (2014)
- Watts R.E., Totsika M., Challinor V.L., Mabbett A.N., Ulett G.C., De Voss J.J., Schembri M.A.: Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80, 333–344 (2012)
- Wiles T.J., Kulesus R.R., Mulvey M.A.: Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85, 11–19 (2008)
- Yang H., Li Q., Wang C., Wang J., Lv J., Wang L., Zhang Z.S., Yao Z., Wang Q.: Cytotoxic necrotizing nactor 1 downregulates CD36 transcription in macrophages to induce inflammation during acute urinary tract infections. Front. Immunol. 9, 1987 (2018)
- Zalewska-Piątek B., Wilkanowicz S., Bruździak P., Piątek R., Kur J.: Biochemical characteristic of biofilm of uropathogenic Escherichia coli Dr+ strains. Microbiol. Res. 168, 367–378 (2013)
- Zalewska-Piątek B.M., Piątek R.J.: Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains. Acta. Biochim. Pol. 66, 129–138 (2019)
- Zaw M.T., Lai Y.M., Lin Z.: Uropathogenic specific protein: epidemiologic marker of uropathogenic Escherichia coli as well as non-specific DNase. Int. J. Collab. Res. Intern. Med. Public Health, 5, 630 (2013)
- Zaw M.T., Yamasaki E., Yamamoto S., Nair G.B., Kawamoto K., Kurazono H.: Uropathogenic specific protein gene, highly distributed in extraintestinal uropathogenic Escherichia coli, encodes a new member of H-N-H nuclease superfamily. Gut. Pathog. 5, 13 (2013)